摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-amino-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]-oct-2-ene-2-carboxylic acid,diphenylmethyl ester | 53090-86-1

中文名称
——
中文别名
——
英文名称
7-amino-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]-oct-2-ene-2-carboxylic acid,diphenylmethyl ester
英文别名
diphenylmethyl 7-amino-3-<(1-methyl-1H-tetrazol-5-yl)thiomethyl>-3-cephem-4-carboxylate;7-amino-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-carboxylic acid,diphenylmethyl ester;7β-amino-3-(1-methyl-5-tetrazolylthiomethyl)-3-cephem-4-carboxylic acid diphenylmethyl ester;7-amino-3-(1-methyl-5-tetrazolyl)thiomethyl-3-cephem-4-carboxylic acid diphenylmethyl ester;7-amino-3-(1-methyl-5-tetrazolyl)thiomethyl-3-cephem-4-carboxylic acid benzhydryl ester;benzhydryl 7-amino-3-[(1-methyltetrazol-5-yl)-thio-methyl]-ceph-3-em-4-carboxylate;7-Amino-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, diphenylmethyl ester;benzhydryl 7-amino-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
7-amino-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]-oct-2-ene-2-carboxylic acid,diphenylmethyl ester化学式
CAS
53090-86-1
化学式
C23H22N6O3S2
mdl
——
分子量
494.598
InChiKey
YDROWRWAIBYYQX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    736.9±70.0 °C(Predicted)
  • 密度:
    1.53±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    34
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.26
  • 拓扑面积:
    167
  • 氢给体数:
    1
  • 氢受体数:
    9

SDS

SDS:3d9c3f26c714560fbaba61ad5df4ba80
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [[[(2,4-Dioxo-1-imidazolidinyl)amino]carbonyl]amino]-acetylcephalosporin
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04063019A1
    公开(公告)日:1977-12-13
    [[[(2,4-Dioxo-1-imidazolidinyl)amino]carbonyl]amino]-acetylcephalosporin derivatives having the formula ##STR1## wherein R is hydrogen, lower alkyl, phenyl-lower alkyl, diphenyl-lower alkyl, tri(lower alkyl)silyl, trihaloethyl, a salt forming ion, or the group ##STR2## R.sub.1 is hydrogen or methoxy; R.sub.2, R.sub.3 and R.sub.5 each is hydrogen or lower alkyl; R.sub.4 is hydrogen, lower alkyl, cyclo-lower alkyl, cyclo-lower alkenyl, cyclo-lower alkadienyl, phenyl, phenyl-lower alkyl, substituted phenyl, substituted phenyl-lower alkyl, or certain heterocyclic groups; R.sub.6 is lower alkyl; and X is hydrogen, lower alkanoyloxy, ##STR3## or certain heterothio groups; are useful as antibacterial agents.
    (2,4-二氧代-1-咪唑烷基)氨基甲酰氨基-头孢菌素衍生物具有以下结构式##STR1##其中R为氢、低烷基、苯基-低烷基、二苯基-低烷基、三(低烷基)硅基、三卤乙基、形成盐的离子,或基团##STR2##R.sub.1为氢或甲氧基;R.sub.2、R.sub.3和R.sub.5各自为氢或低烷基;R.sub.4为氢、低烷基、环-低烷基、环-低烯基、环-低烷二烯基、苯基、苯基-低烷基、取代苯基、取代苯基-低烷基,或某些杂环基团;R.sub.6为低烷基;X为氢、低烷酰氧基、##STR3##或某些杂硫基团;可用作抗菌剂。
  • A new synthesis of 3-chloro-2-(thiazol-4-yl)propenoic acid and its application to cephalosporins.
    作者:KIYOHARU NISHIDE、MARIKO YAMAMURA、MAYUMI YAMAZAKI、TAKEO KOBORI、DAIEI TUNEMOTO、KIYOSI KONDO、KIYOSHI SATO
    DOI:10.1248/cpb.36.2346
    日期:——
    Three step transformations of α-formylation, chlorination and hydrolysis starting from ethyl 4-thiazoleacetate (1) afforded a new cephem 7-side chain acid, (E)-3-chloro-2-(thiazol-4-yl)propenoic acid (4-(E)). The presence of the corresponding 4-(Z) derived from photoisomerization of 4-(E) was confirmed by nuclear magnetic resonance analysis. Acylation of several 7-aminocephalosporins was conducted by two routes involving the photoisomerization of 4-(E) to 4-(Z) (method A) or the isomerization of the activated intermediate (formula III) of the carboxylic acid 4-(E) with Vilsmeier reagent by heating (method B). The synthesis and the antibacterial activities of a new series of geometrical isomers of 7-[3-chloro-2-(thiazol-4-yl)propenamido] cephalosporins (formula II) are described.
    从 4-噻唑乙酸乙酯(1)开始,经过α-甲酰化、氯化和水解三个步骤的转化,得到了一种新的头孢 7 侧链酸,即(E)-3-氯-2-(噻唑-4-基)丙烯酸(4-(E))。核磁共振分析证实了 4-(E)光异构化产生的相应 4-(Z)的存在。几种 7-氨基头孢菌素的酰化有两种途径,一种是 4-(E)光异构化成 4-(Z)(方法 A),另一种是羧酸 4-(E)的活化中间体(式 III)与 Vilsmeier 试剂加热异构化(方法 B)。本文介绍了 7-[3-氯-2-(噻唑-4-基)丙烯酰胺基]头孢菌素(式 II)的一系列新几何异构体的合成和抗菌活性。
  • 3-Heterothio derivatives of (.alpha.-thiocarbonylamino) cephalosporins
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US03996219A1
    公开(公告)日:1976-12-07
    3-Heterothio(.alpha.-thiocarbonylamino)cephalosporin derivatives of the general formula ##STR1## wherein R is hydrogen, lower alkyl, phenyl-lower alkyl, tri(lower alkyl)silyl, trihaloethyl, a salt forming ion or the group ##STR2## R.sub.1 is hydrogen, lower alkyl, cyclo-lower alkyl, unsaturated cyclo-lower alkyl, phenyl, substituted phenyl or thienyl; R.sub.2 and R.sub.5 each is hydrogen or lower alkyl; R.sub.3 is a five or six membered nitrogen, sulfur and/or oxygen containing ring system; and R.sub.4 is lower alkyl, phenyl or phenyl-lower alkyl; are useful as antibacterial agents.
    3-杂硫(.alpha.-硫代氨基)头孢菌素衍生物的一般式为##STR1##其中R为氢、低碳基、苯基-低碳基、三(低碳基)硅基、三卤乙基、盐形成离子或基团##STR2##R.sub.1为氢、低碳基、环-低碳基、不饱和环-低碳基、苯基、取代苯基或噻吩基;R.sub.2和R.sub.5各为氢或低碳基;R.sub.3为五元或六元含氮、硫和/或氧的环系统;R.sub.4为低碳基、苯基或苯基-低碳基;可用作抗菌剂。
  • 3-HETEROTHIOMETHYL UREIDO CEPHALOSPORINS
    申请人:E. R. Squibb & Sons, Inc.
    公开号:US04127716A1
    公开(公告)日:1978-11-28
    L-Isomer compounds of the formula ##STR1## wherein R.sub.1 is phenyl, thienyl or furyl; R.sub.4 represents certain heterocyclic groups; R.sub.3 is hydrogen, lower alkyl, phenyl-lower alkyl, substituted phenyl-lower alkyl, diphenyl-lower alkyl, tri(lower alkyl)stannyl, tri(lower alkyl)silyl, a salt forming ion, or the group ##STR2## wherein R is lower alkyl, phenyl, phenyl-lower alkyl, or substituted phenyl and phenyl-lower alkyl are disclosed. These compounds are useful as antibacterial agents.
    化合物的L-异构体的化学式为##STR1## 其中R.sub.1为苯基,噻吩基或呋喃基; R.sub.4代表某些杂环基团; R.sub.3为氢,低碳基,苯基-低碳基,取代苯基-低碳基,二苯基-低碳基,三(低碳基)亚锡基,三(低碳基)硅基,形成盐的离子,或者是##STR2## 其中R为低碳基,苯基,苯基-低碳基,或者是取代苯基和苯基-低碳基。这些化合物可用作抗菌剂。
  • SAKAGAMI, KENJI;ATSUMI, KUNIO;YOSHIDA, TAKASHI;NISHIHATA, KEN, YAKUGAKU DZASSI, 109,(1989) N, S. 377-387
    作者:SAKAGAMI, KENJI、ATSUMI, KUNIO、YOSHIDA, TAKASHI、NISHIHATA, KEN
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐